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The  mechanisms  for  regulating  antigen-reactive  immune  responses  are  highly 
organized at  different  levels.  Specificity within  this organization  is to a  large extent 
derived  from genotypically-defined networks of bidirectionally communicating anti- 
body and cell-mediated circuits  (1-5). Networks related by complementary idiotypes 
seem particularly subject to immune modulation and can be effectively regulated by 
a  formal  process  of anti-idiotypic  immunity  (6,  7).  Regulation  at  this  level can  be 
operationally defined not only for immune responses expressing a  dominant idiotype 
(8, 9)  but  also when  the idiotypic repertoire  is considerably heterogenous  (10). This 
latter aspect makes anti-idiotypic immunity conceptually applicable to a wide variety 
of immune responses. 
At  the  present  time  there  are  numerous  mechanisms  for inducing  anti-idiotypic 
immunity  (11-15).  T  lymphoblasts,  for  example,  make  an  excellent  immunogen 
because they presumably express an increased density of idiotype on their cell surface 
(15, 16). Selective unresponsiveness induced in naive recipients by injecting autologous 
antigen-reactive  T  lymphoblasts  has  been  demonstrated  across  histocompatibility 
barriers  (16,  17)  with nominal antigens  (18)  and has been shown to abrogate tumor 
resistance (19). This suppressive modulation is mediated through complex interactions 
between  autologous immune  functions collectively derived  from anti-idiotypic  lym- 
phocytes (5,  15,  17,  19). 
We used  an experimental  model of nephritis  to examine the  question of whether 
auto-anti-idiotypic immunity can regulate the expression of an autoimmune disease. 
Rodents  immunized  with  renal  tubular  basement  membrane  antigens  develop  a 
severe and often fatal interstitial  nephritis  (20-23). Antitubular basement membrane 
antibodies  (aTBM-Ab) 1  (24,  25),  monocytes  (25),  natural  killer  cells  (26),  and 
sensitized  T  effector cells  (27,  28)  all  potentially contribute  to the expression of this 
renal  lesion.  Under  the  assumption  that  tubular  antigen-specific  immune  processes 
share common and relatively restricted idiotypes, Brown et al.  (29) have been able to 
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attenuate the development of interstitial nephritis with passively transferred, heter- 
ologous anti-idiotypic antibodies directed against tubular-bound aTBM-Ab. We now 
report that  the pretreatment  of naive rats with tubular antigen-reactive T  lympho- 
blasts  abrogates  the  appearance  of  interstitial  nephritis  when  such  animals  are 
subsequently challenged with tubular antigens in adjuvant. Protected animals devel- 
oped  anti-idiotypic antibodies  against  monoclonal  aTBM-Ab  (MaTBM-Ab),  sug- 
gesting that  their failure to express disease may be the result  of auto-anti-idiotypic 
immunity. 
Materials  and  Methods 
Animals.  Brown Norway rats (BN) were obtained through the Department of Laboratory 
and Animal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pa. 
Antigens.  Rabbit renal tubular basement  membrane  antigens and  rabbit  liver basement 
membranes were isolated by a  differential seiving technique (20).  Highly enriched basement 
membrane fragments were sonicated, lyophilized, and stored at -70°C. Soluble renal tubular 
antigens (SRTA) and soluble liver antigens (SLA) were made from these lyophilized  membranes 
using a 4 M  KCl-phosphate buffer extraction system, as previously described (20, 26). 
Preparation of Donor Lymphoblasts.  Naive animals were immunized with 2 mg of renal tubular 
basement membrane antigens in complete Freund's adjuvant (CFA) by footpad injection (20). 
14 d  later, cell suspensions were made from draining lymph nodes. This mixed population of 
mononuclear cells was T cell enriched by macrophage and B cell depletion using glass beads to 
remove adherent cells (30,  31).  Under  these conditions, using previously established criteria 
(20),  lymphocytes in the nonadherent fraction averaged <10% B cells and macrophages. After 
T  cell enrichment, lymphocytes were cultured in RPMI  1640 supplemented with penicillin G 
(100  U/ml), streptomycin (100/zg/ml),  gentamycin  (25  p,g/ml),  L-glutamine (2  mM),  N-2- 
hydroxyethylpiperazine-N1-2-ethanesulfonic  acid (10 mM), 2-mercaptoethanol (5 ×  10  -2 mM), 
and 5%  heat-inactivated fetal calf serum.  Bulk cultures were performed in  flasks at  2 ×  10  7 
cells/4  ml.  A  soluble  antigen  was  added  to  each  flask  in  an  optimum  concentration.  T 
lymphocyte cultures from rats with nephritis were incubated in the presence of SRTA (5 fig/ 
ml) or SLA (5/ag/ml). Nonreactive T  lymphoeytes from rats immunized with CFA alone were 
also incubated with SRTA (5/zg/ml). Incubations were carried out at 37°C in 5% CO2.  After 
4 d in culture, the antigen-reactive lymphoblasts were isolated by equilibrium density centrif- 
ugation (19, 32). Lymphoblast separation was performed by resuspending 15 ×  107 to 25 ×  10 v 
cells in a solution of bovine serum albumin (density, 1.082) that was overlayed with a less dense 
solution of bovine serum albumin (BSA) (density, 1.060). Gradients were spun to equilibrium 
at  10,000 g for 30 min at 4°C. The less dense lymphoblasts were removed from the interface. 
Control cultures incubated with SRTA did not respond with blast transformation, and these 
nonreactive lymphocytes were spun through Ficoll-Hypaque to remove dead cells. Purity of the 
lymphoblast separation was routinely determined microscopically by size and, periodically, by 
tritiated thymidine (3HTdR) uptake. By these methods, between 80 to 90% of cells in the blast 
fraction were considered to be T  lymphoblasts containing < I% B cells. Viability of the cells in 
the lymphoblast fraction were routinely >90% as determined by trypan blue exclusion. 
Experimental Protocol.  Donor T  lymphoblasts or nonreactive lymphocytes were emulsified in 
adjuvant. Three groups of naive rats received five serial intraperitoneal injections of cells. The 
first  injections  were  in  CFA  (0.5  ml  per  Mycobacterium tuberculosis  1  mg/animal),  and  the 
remaining four injections were in incomplete Freund's adjuvant. Injections were given at 2-wk 
intervals, with each animal receiving on the average of 5 ×  10  ° cells/injection for a mean total 
dose of 2.5  X  107 cells. The three experimental groups were identified as follows: (a)  RTA, 
naive rats receiving T lymphoblasts harvested from lymphocyte cultures from nephritic animals 
coincubated  with  SRTA;  (b)  LA-C,  naive  rats  receiving T  lymphoblasts  harvested  from 
lymphocyte cultures from  nephritic animals coincubated with SLA. This group served as a 
specificity  control for any nonspecific anti-rabbit response; and (c) RTA-C, naive rats receiving 
nonreactive lymphocytes harvested from lymphocyte cultures from nonnephritic control ani- 
mals coincubated with SRTA. This later group served as a control for antigen carryover. 2 wk ERIC  G.  NEILSON AND S.  MICHAEL  PHILLIPS  181 
after the last injection, all three groups were immunized by footpad injection with 2 mg of 
renal tubular basement membrane antigen in CFA, as described above. 21 d later, all groups 
were killed for further analysis. 
Immunologic Evaluation of Lymphoblast-pretreated Recipients 
ASSESSMENT OF IN VITRO LYMPHOCYTE REACTIVITY.  Cells from draining lymph nodes were T 
cell enriched by macrophage and B cell depletion on glass beads, as previously described (20). 
2.5 ×  105 T  lymphocytes in 0.2 ml of complete media were cocultured in triplicate microtiter 
wells in the presence or absence of concanavalin  A (Con A) (10 #g/ml), SRTA (5 #g/m]), SLA 
(5/Lg/ml), and purified protein derivative (PPD;  10/~g/ml) at 37°C in 5% CO2 (20). Cultures 
were 3HTdR labeled during the last 4 h before harvesting for scintillation counting. The ratio 
of mean cpm  from  stimulated cultures per  mean cpm  from  control cultures was  used  to 
determinethe stimulation index _+ SEM. 
AssAYs VOR Ar~THmOTYPm  ANTmODmS.  MaTBM-Ab were produced by polyethylene glycol 
fusion (33).  Lymph node cells  harvested from  BN rats  14 d  after immunization with renal 
tubular basement membrane antigens were fused with Sp2/0-Ag- 14 nonsecreting  plasmacytoma 
cells  (gift  of R.  Kennett, Human Genetics, University of Pennsylvania, Philadelphia, Pa.). 
Positive clones were identified by indirect fluorescent (IF) criteria on BN kidney sections (20). 
Hybridoma BN52/19 was selected  for  use  in the present studies because of its stability and 
selectivity for cortical tubules. BN52/19 binds all proximal tubules and a large percentage of 
distal  tubules. These  antibodies were  also  occasionally reactive with  Bowman's capsule.  A 
similar range of binding specificities  has been previously described (22; unpublished observa- 
tions) in BN rats immunied with xenogeneic tubular basement membrane antigens. BN52/19 
was further subcloned twice in semisoft  agarose and was partially purified by DEAE-cellulose 
chromatography (34). It is an IgG antibody that fails to bind to kidney sections from Lewis 
rats, which do not have tubular antigens relevant to this form of interstitial kidney disease (22). 
MaTBM-Ab BN52/19 provided potential idiotype determinants for binding  studies performed 
with antisera from lymphoblast-pretreated animals. 
Anti-idiotypic antibodies were identified by both sheep erythrocyte (SRBC) hemagglutina- 
tion or by solid-phase radioimmunoassay (RIA). BN52/19-eoated SRBC were prepared using 
the chromic chloride method of Gold and Fudenberg (35). Anti-idiotypic  antibody titers were 
determined by hemagglutination of coated SRBC. Inhibition of hemagglutination was deter- 
mined by the ability of serial dilutions of SRTA to prevent binding. Hemagglutination titers 
were reported as the log2 of the reciprocal of the highest dilution of serum giving agglutination. 
For  the  solid-phase  RIA,  12~I-BN52/19  was  prepared  by  the  chloramine-T method  of 
Klinman and Howard  (36).  The solid-phase assay was  performed in modification from the 
methods of McKearn (37) and Bosma et al. (38, 39). Optimum concentrations  of cold BN52/19 
in 0.02 M  PO4 buffer were  incubated overnight at 4°C in PVC microtiter plates. The plates 
were washed  and blocked for  1 h  with  1%  BSA.  Serial dilutions of test  antisera were  then 
incubated at  22°C  for  4  h.  After further washing,  125I-BN52/19  (40,000  cpm/100 ~1)  was 
overlaid and incubated for  an additional 4  h.  Individual wells  were counted in a  gamma 
spectrophotometer, and the results were expressed  as a percent of maximum bound counts. The 
specificity of binding was determined by binding inhibition  studies using SRTA, SLA, control 
hybridoma, and nonspecific test antisera. 
Assessment of Renal Disease.  Kidney tissue was prepared  for  immunofluorescent and light 
microscopy by  standard  methods  for  this  laboratory,  as  previously described  (20). Direct 
fluorescences  of proximal tubular staining by aTBM-Ab were graded 0-4+ and expressed  as a 
mean  +  SEM  for  each  group.  The  degree  of interstitial involvement was  quantitated by 
weighing tracing paper representations of projected histologic kidney sections to determine a 
percent peripheral cortical involvement +  SEM in modification of the methods of Brown et al. 
(29). aTBM-Ab titers were determined by an IF technique (20) and by a solid-phase RIA in 
modification from  Brown et  al.  (29).  For the  RIA,  25 btg/well  of sonicated renal tubular 
basement membrane antigen in 0.1 ml of 0.1 M sodium carbonate buffer (pH 9.6) was annealed 
to a PVC microtiter plate, using 10 btg/ml of 1-ethyl-3-(3-diethylaminopropyl)  carbodiimide at 
4°C for  16 h.  The wells were blocked with 0.1  M  ammonium chloride for  30 min at  22°C 
followed by 1% BSA for 30 min. The plates were then overlaid with serial dilutions of test sera 
for 4 h at 22°C and subsequently incubated with ~25I-goat anti-rat IgG for an additional 4 h. 182  AUTO-ANTI-IDIOTYPIC IMMUNITY 
The results were expressed as a percent of maximum bound counts.  The specificity of binding 
was determined by binding inhibition studies  using SRTA, SLA, and BSA, and nonspecific 
test antigens. 
Statistical Analysis.  Differences between data were determined by Student's t test. 
Results 
General  Considerations.  The lymphoblasts used in the pretreatment injections were 
markedly depleted of B cells and macrophages and thus were primarily the result of 
T  cell division. The LA-C group received lymphoblasts from cultures responding to 
SLA. These animals served as a control for any anti-rabbit responses to the xenogeneic 
tubular antigen (20, 26, 28). As an additional control, the issue of SRTA carryover in 
the blast fraction was compensated by using nonreactive lymphocytes also incubated 
with tubular antigens (RTA-C). If such antigen contamination occurred, it was likely 
due to antigen  bound to macrophages, which should be equally represented in both 
RTA and RTA-C groups. 
Effects of T  Lymphoblast Pretreatment  on the Expression of Interstitial Nephritis.  In Table 
I, rats pretreated with tubular antigen-reactive lymphoblasts (RTA)  and then chal- 
lenged with  renal  tubular  basement  membrane antigens  in  CFA developed signifi- 
cantly less interstitial inflammation than the RTA-C controls (P <  0.001). The extent 
of disease  in  the  LA-C specificity control  was  equally  as  great  as  that  seen  in  the 
RTA-C group, suggesting that the protection demonstrated for the RTA group was 
tubular antigen-specific. The inflammatory changes in the cortical interstitium  (Fig. 
1) were characterized by heavy mononuclear infiltrates around damaged tubules (20, 
22,  25).  In  some  areas,  groups  of tubules  also  seemed  paler  than  the  surrounding 
healthy tissue. Because animals were sacrificed on day 21,  the lesions were primarily 
found in the peripheral cortex  (22).  The glomeruli in the kidneys from RTA-C and 
LA-C animals generally remained uninvolved. Direct immunofluorescence on cryostat 
sections of renal tissue showed less linear staining of the tubules by aTBM-Ab in the 
RTA group (Table I). The decrease in binding was also reflected in decreased levels 
of aTMB-Ab in the serum of this group determined by IF and RIA criteria.  In Fig. 
2,  the  binding  plot  of aTBM-Ab  titers  from the  RTA  group  also  demonstrated  a 
markedly decreased  slope compared with  RTA-C  rats,  suggesting  a  difference not 
TABLE  I 
Extent of lnterstitial Nephritis 
Percent  Serum aTBM-Ab 
Groups*  N  peripheral:~  corti-  Kidney-bound§ 
aTBM-Ab  cal  involvement  IFII  RIA¶ 
RTA  7  5.2 +  0.7**  1.1  -. 0.5  40  36 
LA-C  6  41.7  ::t= i2.7  3.8 +  0.2  80  68 
RTA-C  6  37.5 :t: 7.0  4,0 +  0,0  150  100 
* Defined in Materials and Methods. 
:~ Determined by weighing tracing paper representations of histologic kidney sections. 
§ Direct fluorescence of cryostat kidney sections. 
II Reciprocal of the highest serum dilution using IF binding. 
¶ Percent  of maximum bound counts of neat  serum to sonicated tubular antigen. 
Binding of aTBM-Ab  in this assay was inhibited  to  24%  of maximum binding 
with 65 mg of SRTA, but only to 89% with SLA. 
** P<  0.001 compared with RTA-C. ERIC G.  NEILSON  AND  S.  MICHAEL PHILLIPS  183 
Ftc.  1.  Kidney sections representative of the areas of peripheral cortical involvement. (A) RTA 
rats;  (B) LA-C rats; (C)  RTA-C rats. Lesions, when they occurred (groups B and  C), produced 
tubular  destruction  and  mononuclear  cell involvement in  the  interstitium  typical  of previous 
descriptions (22) (H and E, 160X). 
only in absolute titer but also in binding affinity. Binding in this assay was specifically 
inhibitable  by SRTA but not by SLA (Table I). 
Effects of T Lymphoblast Pretreatment on Lymphocyte Responsiveness to Soluble Antigens.  At 
killing,  T  lyrnphocytes from all  three experimental  groups were coincubated with  a 
panel  of soluble antigens  and  mitogens.  In Table II, it can be seen that  lymphocyte 
responsiveness  reflected  in  the  stimulation  index  was  comparatively  equal  among 
groups with Con A and PPD. The response against SRTA, however, was significantly 
less in protected RTA animals compared with the RTA-C group (P <  0.001).  There 
was no significant reactivity in any of the groups with SLA, suggesting that the SRTA 
response was specific for tubular antigens, as previously described  (20, 26, 28). 
Effects of T Lymphoblast Pretreatment on the Development of Anti-Idiotypic Antibodies. Sera 
from all  three  groups  obtained  at  killing  were  tested  for binding  reactivity  against 
syngeneie  MaTBM-Ab  (BN52/19).  This  monoclonal  antibody  meets  reasonable 
criteria  for  a  relevant  aTBM-Ab.  It  is  an  IgG  molecule  produced  by  fusion  with 
lymph node cells harvested  from BN rats immunized with tubular  antigens  in CFA. 184  AUTO-ANTI-IDIOTYPIC  IMMUNITY 
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Fla.  2.  Analysis of aTMB-Ab  binding to tubular antigen. A  comparison of serial dilutions of 
serum from RTA (0) and RTA-C (I) groups demonstrates a lower titer ofaTBM-Ab in protected 
RTA rats as well as a change in slope, suggesting a reduction in binding affinity of these antibodies. 
Results with antisera from LA-C rats (not shown) were intermediate but more similar to the RTA- 
C group, aTBM-Ab binding was inhibitable with SRTA (see Table I). 
TAnLE  II 
Lymphocyte Responsiveness to Mitogen and Soluble Antzgens 
Stimulation index* 
Groups  N 
Con A~  PPD  SLA  SRTA 
RTA  7  20.0 +  4.3  3.2 +  0.5  1.1 +  0.1  1.7 +  0.2§ 
LA-C  6  13.7=1=2.1  4.2-1-0.8  1.3+0.1  4.1-t-0.7 
RTA-C  6  18.8-t-2.2  4.2+0.5  1.1 +0.1  3.5:1=0.4 
* Counts per minute stimulated/cpm unstimulated +  SEM. 
:1: Harvested after 72 h. Cultures coincubated with other antigens were harvested after 
96 h. 
§ P< 0.001 compared with RTA-C. 
BN52/19  binds primarily  to cortical tubules of BN  but  not  Lewis rats.  Lewis rats do 
not seem to express this nephritogenic  tubular  antigen  (22).  Using an SRBC  hemag- 
glutination  assay,  sera from  RTA  animals  hemagglutinated  BN52/19-coated  SRBC 
to  a  significantly greater degree  than  sera from  LA-C  or  RTA-C  groups  (titers were 
5,  compared  to  2  and  2,  respectively).  Hemagglutination  inhibition with  SRTA  was 
specific and  complete  at 65 #g of protein. These studies were confirmed  with a  solid- ERIC  G.  NEILSON  AND  S.  MICHAEL  PHILLIPS  185 
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Fio. 3.  Anti-idiotypic  antibody binding to BN52/19 by solid-phase  radioimmunoassay.  0, RTA; 
m, RTA-C;  and l, LA-C  groups. A  comparison of serial  dilutions  of serum from all three 
experimental groups demonstrates the presence of anti-idiotypic binding only with serum from 
protected  RTA animals. Anti-idiotypic antibodies  were not  present in  RTA rats  before their 
immunization with tubular antigens (×). The binding of anti-idiotypic antibodies from protected 
RTA rats was specifically inhibitable with SRTA(O) and control(/~ )) hybridoma compared with 
SLA(f"I) and BSA(A), suggesting the binding was primarily confined to the antigen-binding region 
of BN52/19. 
phase RIA. In Figure 3, RTA animals showed greater binding to BN52/19 than either 
of the  other  two  groups.  Sera  from  RTA  rats  obtained  before  immunization  with 
renal  tubular  basement  membrane  antigens  also  failed  to  bind  to  MaTBM-Ab, 
suggesting  that  the  quantifiable  development  of anti-idiotypic  antibodies  was  in 
response to the subsequent  immunization with tubular antigens. A  50% reduction in 
binding of sera from RTA rats was achieved with 65 #g of SRTA. The specificity of 
this inhibition was confirmed with the nonspecific antigens SLA and BSA. Replacing 
BN52/19-coated  wells  with  control  hybridoma  antibodies  reduced  serum  binding 
from RTA rats by 64%. BN52/19 also failed to bind to other syngeneic proteins (data 
not shown). Binding inhibition with SRTA suggests that the anti-idiotypic antibodies 
in the sera from RTA rats were primarily reacting with determinants  in the antigen- 
binding region of BN52/19. 186  AUTO-ANTI-IDIOTYPIC IMMUNITY 
Discussion 
Rats immunized with renal tubular basement membrane antigens develop signifi- 
cant interstitial nephritis (22). The complete expression of disease depends on complex 
interactions between aTBM-Ab  (24,  25)  and cell-mediated immune responses  (25- 
28). From recent studies (29) it appears that the immune functions mediating disease 
share complemetary idiotypes that can be suppressed by heterologous anti-idiotypic 
antibodies. Our present work further demonstrates under optimum conditions that 
rats  can  also  develop  protective  auto-anti-idiotypic immunity to  a  nephritogenic 
immune response against tubular antigens. 
After pretreatment with tubular antigen-reactive T lymphoblasts, recipient rats fail 
to develop significant interstitial nephritis. These protected animals are specifically 
less  responsive  to  tubular  antigens and  produce  less  aTBM-Ab.  Their serum  also 
contains antibodies that bind primarily to Mc~TBM-Ab in the antigen-binding region, 
as binding is specifically inhibitable with soluble tubular antigen. From inhibition 
studies using control hybridoma, a  further reduction in binding over that seen with 
tubular antigen alone was also observed. This finding suggests that sera from protected 
rats containing anti-idiotypic antibodies might have been multispecific and partially 
directed to nonantigen binding-site determinants to a  lesser  degree. That syngeneic 
anti-idiotypic antibodies  may be  multispecific has  been  previously recognized  by 
others  (12).  Collectively, our findings suggest that protection from disease was the 
result of auto-anti-idiotypic immunity. 
The  ability  of T  lymphoblasts  to  confer  specific  anti-idiotypic  immunity  on 
recipients  has  been  previously  recognized  under  a  wide  variety  of experimental 
conditions  (15-19).  That  we were  able  to  demonstrate anti-idiotypic reactivity to 
binding-site determinants on Mc~TBM-Ab was somewhat fortuitous, as the degree of 
idiotypic diversity  in  aTBM  disease  is  unknown.  The  exact  mechanism  of anti- 
idiotypic immunity in this model is also unclear. Presumably, the unfractionated pool 
of antigen-reactive T lymphoblasts presents a complete spectrum of relevant idiotypes 
to the naive recipient. Using similar protocols, T  lymphoblasts can induce idiotype- 
specific suppressor and cytotoxic T  cells  (17, 19)  in addition to anti-idiotypic anti- 
bodies (15). Although it was not done in the present studies, this suppression can also 
be  transferred with both T  and  B  ceils  (17).  Anti-idiotypic immunity in  nominal 
antigen systems appears to be modulated by complex relationships between antigen- 
and  idiotype-specific suppressor  cells  induced  by  idiotypically-defined suppressor 
factors (3, 5) as well as anti-idiotypic antibodies (5, 40). In view of the many immune 
reactants that can participate in idiotype-specific unresponsiveness, we do not wish to 
imply that anti-idiotypic antibodies alone are the principle mediators of anti-idiotypic 
immunity in the present studies. 
We also observed that lymphocyte responsiveness to tubular antigens was specifi- 
cally depressed  in  rats  protected  with  tubular  antigen-reactive lymphoblasts. Our 
findings confirm the results of Green and Sy (5), who reported that idiotypic structures 
can induce antigen-specific inhibition of proliferation and delayed hypersensitivity by 
T  cells.  In the present experiment, c~TBM-Ab  from protected animals also demon- 
strated a reduced binding affinity for tubular antigen, These results suggest that anti- 
idiotypic immunity might  have  had  a  modulating influence both  at  the  level  of 
antigen recognition and in the development of antigen-receptor heterogeneity. De- ERIC G.  NEILSON AND S.  MICHAEL PHILLIPS  187 
velopmental  failures  in  these  two  processes  ultimately  presaged  the  overall  ineffec- 
tiveness of antibody and cell-mediated  effector responses at the level of the kidney. 
Summary 
Rats immunized with renal tubular antigens were protected from the development 
of interstitial nephritis by pretreatment with tubular antigen-reactive T  lymphoblasts. 
Protected  animals  developed  anti-idiotypic  antibodies  against  idiotypes  primarily 
within  the  antigen-binding  region  of monoclonal  antitubular  basement  membrane 
antibodies.  These  studies  extend  the  concept  of auto-anti-idiotypic  regulation  to 
autoimmune  disease, and  they also provide an experimental  basis for further efforts 
to develop  biologically  relevant  mechanisms  for attenuating  the  expression of other 
kidney diseases. 
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